Mallinckrodt Plc Management
MNKDelisted Stock | USD 0.46 0.02 4.17% |
Mallinckrodt Plc employs about 2.7 K people. The company is managed by 23 executives with a total tenure of roughly 117 years, averaging almost 5.0 years of service per executive, having 116.22 employees per reported executive. Inspection of Mallinckrodt Plc's management performance can provide insight into the company performance.
Mark Trudeau CEO CEO and President Director and Member of Portfolio Committee |
Angus Russell Chairman Independent Non-Executive Chairman of the Board |
Mallinckrodt |
Mallinckrodt Plc Management Team Effectiveness
Mallinckrodt Plc's management efficiency ratios could be used to measure how well Mallinckrodt Plc manages its routine affairs as well as how well it operates its assets and liabilities.Mallinckrodt Plc Workforce Comparison
Mallinckrodt Plc is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 9,289. Mallinckrodt Plc totals roughly 2,673 in number of employees claiming about 29% of equities under Health Care industry.
The company has Net Profit Margin of (0.83) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.01) %, which entails that for every $100 of revenue, it lost $0.01. Mallinckrodt Plc Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mallinckrodt Plc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mallinckrodt Plc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Mallinckrodt Plc insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jason Goodson over a year ago Payment of 5545 shares by Jason Goodson of Mallinckrodt Plc subject to Rule 16b-3 | ||
Lisa French over a year ago Disposition of 134590 shares by Lisa French of Mallinckrodt Plc subject to Rule 16b-3 | ||
Eldada Riad Hussein over a year ago Payment of 3154 shares by Eldada Riad Hussein of Mallinckrodt Plc subject to Rule 16b-3 | ||
Eldada Riad Hussein over a year ago Disposition of 22533 shares by Eldada Riad Hussein of Mallinckrodt Plc subject to Rule 16b-3 | ||
Lisa French over a year ago Acquisition by Lisa French of 134590 shares of Mallinckrodt Plc subject to Rule 16b-3 | ||
Jason Goodson over a year ago Purchase by Jason Goodson of 200 shares of Mallinckrodt Plc | ||
Bisaro Paul over a year ago Purchase by Bisaro Paul of 5000 shares of Mallinckrodt Plc | ||
Richardson Peter C over a year ago Acquisition by Richardson Peter C of 75091 shares of Mallinckrodt Plc subject to Rule 16b-3 |
Mallinckrodt Plc Notable Stakeholders
A Mallinckrodt Plc stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Mallinckrodt Plc often face trade-offs trying to please all of them. Mallinckrodt Plc's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Mallinckrodt Plc's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mark Trudeau | CEO and President Director and Member of Portfolio Committee | Profile | |
Angus Russell | Independent Non-Executive Chairman of the Board | Profile | |
Hugh ONeill | Executive Vice President and President, Autoimmune and Rare Diseases | Profile | |
Steven Romano | Executive Vice President and Chief Scientific Officer | Profile | |
Bryan Reasons | Chief Financial Officer, Executive Vice President | Profile | |
Mark Casey | Executive Vice President and Chief Legal Officer | Profile | |
Ian Watkins | Chief Human Resource Officer, Executive Vice President | Profile | |
David Norton | Independent Director | Profile | |
Kneeland Youngblood | Independent Director | Profile | |
JoAnn Reed | Independent Director | Profile | |
Paul Carter | Independent Director | Profile | |
Carlos Paya | Independent Director | Profile | |
Anne Whitaker | Independent Director | Profile | |
CPA CPA | Global Officer | Profile | |
Sigurdur Olafsson | Pres CEO | Profile | |
J Carroll | Independent Director | Profile | |
Lisa French | Ex Officer | Profile | |
Kassie Harrold | Ex Officer | Profile | |
Jason Goodson | Exec Devel | Profile | |
Stephen Welch | Ex Generics | Profile | |
Henriette Nielsen | Ex Officer | Profile | |
Steven MD | Ex Officer | Profile | |
Mark Tyndall | Chief VP | Profile |
About Mallinckrodt Plc Management Performance
The success or failure of an entity such as Mallinckrodt Plc often depends on how effective the management is. Mallinckrodt Plc management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Mallinckrodt management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Mallinckrodt management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. The company was founded in 1867 and is based in Dublin, Ireland. Mallinckrodt Plc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on AMEX Exchange. It employs 2778 people.
Mallinckrodt Plc Workforce Analysis
Traditionally, organizations such as Mallinckrodt Plc use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Mallinckrodt Plc within its industry.Mallinckrodt Plc Manpower Efficiency
Return on Mallinckrodt Plc Manpower
Revenue Per Employee | 826.3K | |
Revenue Per Executive | 96M | |
Net Loss Per Employee | 268.4K | |
Net Loss Per Executive | 31.2M | |
Working Capital Per Employee | 483.4K | |
Working Capital Per Executive | 56.2M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Mallinckrodt Stock
If you are still planning to invest in Mallinckrodt Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mallinckrodt Plc's history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |